Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU

Sandra L. Kane-Gill, Joseph F. Dasta, Mitchell S. Buckley, Sandeep Devabhakthuni, Michael Liu, Henry Cohen, Elizabeth L. George, Anne S. Pohlman, Swati Agarwal, Elizabeth A. Henneman, Sharon M. Bejian, Sean M. Berenholtz, Jodie L. Pepin, Mathew C. Scanlon, Brian S. Smith

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

Original languageEnglish (US)
Pages (from-to)1546-1551
Number of pages6
JournalCritical care medicine
Issue number9
StatePublished - Sep 1 2017


  • critical care intensive care unit
  • drug-related side effects and adverse reactions
  • medication errors
  • patient safety
  • safety management

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU'. Together they form a unique fingerprint.

Cite this